Protective effects of endothelial progenitor cell microvesicles on Ang II‑induced rat kidney cell injury

内皮祖细胞微泡对血管紧张素Ⅱ诱导的大鼠肾细胞损伤的保护作用

阅读:10
作者:Yanling Song #, Zhenbing Bai #, Yuanyuan Zhang, Juming Chen, Minghui Chen, Yunbo Zhang, Xiaodian Zhang, Huade Mai, Bingshu Wang, Yunyun Lin, Shenhong Gu

Abstract

Chronic hypertension can lead to kidney damage, known as hypertensive nephropathy or hypertensive nephrosclerosis. Further understanding of the molecular mechanisms via which hypertensive nephropathy develops is essential for effective diagnosis and treatment. The present study investigated the mechanisms by which endothelial progenitor cells (EPCs) repair primary rat kidney cells (PRKs). ELISA, Cell Counting Kit‑8 and flow cytometry assays were used to analyze the effects of EPCs or EPC‑MVs on the oxidative stress, inflammation, cell proliferation, apoptosis and cycle of PRKs induced by AngII. A PRK injury model was established using angiotensin II (Ang II). After Ang II induction, PRK proliferation was decreased, apoptosis was increased and the cell cycle was blocked at the G1 phase before entering the S phase. It was found that the levels of reactive oxygen species and malondialdehyde were increased, while the levels of glutathione peroxidase and superoxide dismutase were decreased. Moreover, the levels of the inflammatory cytokines IL‑1β, IL‑6 and TNF‑α were significantly increased. Thus, Ang II damaged PRKs by stimulating oxidative stress and promoting the inflammatory response. However, when PRKs were co‑cultured with EPCs, the damage induced by Ang II was significantly reduced. The current study collected the microvesicles (MVs) secreted by EPCs and co‑cultured them with Ang II‑induced PRKs, and identified that EPC‑MVs retained their protective effect on PRKs. In conclusion, EPCs protect PRKs from Ang II‑induced damage via secreted MVs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。